US FDA Learns 'Lessons Of History,' Takes Opioid Fight To Gabapentinoids

 
• By Derrick Gingery

Agency investigating potential misuse and abuse of gabapentinoids, which CDC had recommended as alternative to opioids, in latest twist to epidemic.

Clouds-Lightning-Storm_1200x675
The pharmaceutical alternative to a problematic pharmaceutical has problems. What are the odds?

More from US FDA

More from Agency Leadership